Cited 4 times in
Impact of atherosclerosis detection by carotid ultrasound on physician behavior and risk-factor management in asymptomatic hypertensive subjects.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박승우 | - |
dc.contributor.author | 송기준 | - |
dc.contributor.author | 장혁재 | - |
dc.contributor.author | 홍그루 | - |
dc.contributor.author | 홍성진 | - |
dc.date.accessioned | 2015-12-28T10:59:20Z | - |
dc.date.available | 2015-12-28T10:59:20Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 0160-9289 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/138454 | - |
dc.description.abstract | BACKGROUND: There are limited data regarding the impact of atherosclerosis detection by carotid ultrasound (CUS) on physician prevention efforts and risk-factor management for cardiovascular disease. HYPOTHESIS: Atherosclerosis detection by CUS in asymptomatic hypertensive patients would lead to physician prevention efforts, including target low-density lipoprotein cholesterol (LDL-C) level and prescription. Also, it may improve risk-factor management. METHODS: A total of 347 asymptomatic hypertensive subjects (age 61 ± 8 years, 189 men) were prospectively recruited from 22 hospitals. Prior to CUS, physicians were surveyed regarding target LDL-C level. After CUS, patients were classified into positive CUS (n = 182) and negative CUS (n = 165) groups based on CUS results. Physicians were resurveyed to assess whether the initial target LDL-C goals were changed. At 6 months, cardiovascular risk-factor modification status was reassessed. RESULTS: The proportion of lowered target LDL-C levels was significantly larger in the positive CUS group than in the negative CUS group (52% vs 23%, P < 0.001). These results were observed even in subjects who had low and moderate risk according to National Cholesterol Education Program-Adult Treatment Panel III guidelines. Lipid-lowering agents were similarly added or switched to another class in both groups (7% in the positive CUS group vs 11% in the negative CUS group, P = 0.153). LDL-C was significantly decreased in the positive CUS group (Δ = -24 ± 38 mg/dL, P < 0.001), whereas it was not significantly decreased in the negative CUS group (Δ = -6 ± 31 mg/dL, P = 0.105). CONCLUSIONS: Atherosclerosis detection by CUS lowered physicians' target LDL-C level and improved cardiovascular risk management in terms of LDL-C reduction. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 91~96 | - |
dc.relation.isPartOf | CLINICAL CARDIOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Asymptomatic Diseases | - |
dc.subject.MESH | Attitude of Health Personnel* | - |
dc.subject.MESH | Biomarkers/blood | - |
dc.subject.MESH | Carotid Arteries/diagnostic imaging* | - |
dc.subject.MESH | Carotid Artery Diseases/blood | - |
dc.subject.MESH | Carotid Artery Diseases/diagnostic imaging | - |
dc.subject.MESH | Carotid Artery Diseases/drug therapy* | - |
dc.subject.MESH | Carotid Artery Diseases/epidemiology | - |
dc.subject.MESH | Carotid Intima-Media Thickness* | - |
dc.subject.MESH | Cholesterol, LDL/blood | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Health Knowledge, Attitudes, Practice* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypertension/diagnosis | - |
dc.subject.MESH | Hypertension/drug therapy* | - |
dc.subject.MESH | Hypertension/epidemiology | - |
dc.subject.MESH | Hypolipidemic Agents/therapeutic use* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Physicians/psychology* | - |
dc.subject.MESH | Practice Patterns, Physicians'* | - |
dc.subject.MESH | Predictive Value of Tests | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Republic of Korea/epidemiology | - |
dc.subject.MESH | Risk Assessment | - |
dc.subject.MESH | Risk Factors | - |
dc.title | Impact of atherosclerosis detection by carotid ultrasound on physician behavior and risk-factor management in asymptomatic hypertensive subjects. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Sung Jin Hong | - |
dc.contributor.googleauthor | Hyuk Jae Chang | - |
dc.contributor.googleauthor | Kijun Song | - |
dc.contributor.googleauthor | Geu Ru Hong | - |
dc.contributor.googleauthor | Seung Woo Park | - |
dc.contributor.googleauthor | Hyun Jae Kang | - |
dc.contributor.googleauthor | Eung Ju Kim | - |
dc.contributor.googleauthor | Dong Soo Kim | - |
dc.contributor.googleauthor | Myung Ho Jeong | - |
dc.identifier.doi | 10.1002/clc.22220 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01551 | - |
dc.contributor.localId | A02016 | - |
dc.contributor.localId | A03490 | - |
dc.contributor.localId | A04386 | - |
dc.contributor.localId | A04403 | - |
dc.relation.journalcode | J00565 | - |
dc.identifier.eissn | 1932-8737 | - |
dc.identifier.pmid | 24193449 | - |
dc.contributor.alternativeName | Park, Seung Woo | - |
dc.contributor.alternativeName | Song, Ki Jun | - |
dc.contributor.alternativeName | Chang, Hyuck Jae | - |
dc.contributor.alternativeName | Hong, Geu Ru | - |
dc.contributor.alternativeName | Hong, Sung Jin | - |
dc.contributor.affiliatedAuthor | Park, Seung Woo | - |
dc.contributor.affiliatedAuthor | Song, Ki Jun | - |
dc.contributor.affiliatedAuthor | Chang, Hyuck Jae | - |
dc.contributor.affiliatedAuthor | Hong, Geu Ru | - |
dc.contributor.affiliatedAuthor | Hong, Sung Jin | - |
dc.citation.volume | 37 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 91 | - |
dc.citation.endPage | 96 | - |
dc.identifier.bibliographicCitation | CLINICAL CARDIOLOGY, Vol.37(2) : 91-96, 2014 | - |
dc.identifier.rimsid | 45322 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.